title: Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report.
authors.affiliation: Department of Surgery II, Osaka University Medical School, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kita
authors.forename: Y
authors.initials: Y
authors.lastname: Beck
authors.forename: S
authors.initials: S
authors.lastname: Teraoka
authors.forename: K
authors.initials: K
authors.lastname: Yokota
authors.forename: Y
authors.initials: Y
authors.lastname: Andoh
authors.forename: T
authors.initials: T
authors.lastname: Nagao
authors.forename: M
authors.initials: M
authors.lastname: Gotoh
authors.forename: M
authors.initials: M
authors.lastname: Sakon
authors.forename: M
authors.initials: M
authors.lastname: Monden
mesh_terms: D000328:Adult; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery* / Q000821:virology; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis; D012008:Recurrence; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D005765:Gastrointestinal Agents; D012367:RNA, Viral; D014580:Ursodeoxycholic Acid